Risk of cancer in transplant patients treated with recombinant growth hormone
Growth hormone (GH) is a potent stimulator of insulin-like growth factor- 1 (IGF-1), which in its turn has been proven to stimulate both cell proliferation and protein synthesis in various systems. Thus, the question may be raised whether the therapeutic use of GH, particularly in transplant patients, may increase the risk of developing malignant tumors or causing recurrence of a previous tumor that is thought to be under control .
KeywordsGrowth Hormone Transplant Patient Growth Hormone Treatment Growth Hormone Therapy Bloom Syndrome
Unable to display preview. Download preview PDF.
- 4.Wilton R Adverse effect during growth hormone treatment: 5 years’ experience in the Kabi International Growth Study. In: Ranke MB, Gunnarsson R, editors. Progress in Growth Hormone Therapy — 5 years of the KIGS. Mannheim, Germany: J & J Verlag, 1994: 291–307.Google Scholar